Home › Funds › BAR HARBOR WEALTH MANAGEMENT › REGN
BAR HARBOR WEALTH MANAGEMENT position in REGN
REGENERON PHARMACEUTICALS · Health Care
BAR HARBOR WEALTH MANAGEMENT reported holding 14,381 shares of REGN (REGENERON PHARMACEUTICALS) in its Q3 2026 13F filing — a position valued at US$10.9M, representing 0.60% of its reported portfolio and ranking #43 among its reported holdings. BAR HARBOR WEALTH MANAGEMENT has disclosed REGN holdings in 6 of the last 6 reported quarters, going back to Q2 2025.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How BAR HARBOR WEALTH MANAGEMENT's REGN position evolved
BAR HARBOR WEALTH MANAGEMENT first disclosed a stake in REGN in Q2 2025 at 8,976 shares (US$4.7M). The position peaked in Q1 2026 at 14,714 shares, worth US$11.4M. Across 6 filings, BAR HARBOR WEALTH MANAGEMENT increased the stake 2 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 14,381 shares valued at US$10.9M — a reduction of -222 shares quarter over quarter.. Notable position changes include a 37% increase in Q3 2025 (shares rose 36% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2025 | 8.98K | $4.71M | New |
| Q3 2025 | 12.28K | $6.90M | Add |
| Q4 2025 | 14.70K | $11.34M | Add |
| Q1 2026 | 14.71K | $11.37M | Hold |
| Q2 2026 | 14.60K | $9.11M | Reduce |
| Q3 2026 | 14.38K | $10.90M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About REGN and 13F data
REGN (REGENERON PHARMACEUTICALS) is a Health Care company. 29 other funds we track also report a position in REGN — the largest reported positions include Dodge & Cox (US$3.04B), DODGE & COX (US$3.04B), Franklin Resources (US$2.75B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding REGN
- Dodge & Cox 4.87M sh · $3.04B · Q2 2026
- DODGE & COX 4.87M sh · $3.04B · Q2 2026
- Franklin Resources 2.95M sh · $2.75B · Q3 2026
- Nuveen, LLC 1.96M sh · $1.48B · Q3 2026
- LOOMIS SAYLES & CO L P 1.72M sh · $1.30B · Q3 2026
More on BAR HARBOR WEALTH MANAGEMENT
FAQ
How long has BAR HARBOR WEALTH MANAGEMENT held REGN?
BAR HARBOR WEALTH MANAGEMENT has disclosed REGN holdings in 6 of the last 6 reported quarters, going back to Q2 2025.
What is BAR HARBOR WEALTH MANAGEMENT's current position in REGN?
As of Q3 2026, BAR HARBOR WEALTH MANAGEMENT holds 14.38K shares of REGN (REGENERON PHARMACEUTICALS), valued at $10.90M, representing 0.60% of its reported portfolio and ranking #43.
Has BAR HARBOR WEALTH MANAGEMENT been buying or selling REGN?
In the latest 13F filing (Q3 2026), BAR HARBOR WEALTH MANAGEMENT reduced its position in REGN. The position peaked in Q1 2026 at 14.71K shares.
Which other funds hold REGN?
Other major institutional holders of REGN include Dodge & Cox, DODGE & COX, Franklin Resources, among 29 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.